EcoDrugPlus

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSAPOG00000003674
Gene Symbol: LOC110955923
3 Cross references
192 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSAPOG00000019565
Gene Symbol: LOC110951999
3 Cross references
197 Possible Orthologues:

Uncharacterized Loc110967334

Ensembl ID : ENSAPOG00000017489
Gene Symbol: LOC110967334
2 Cross references
192 Possible Orthologues:

Uncharacterized Loc110970708

Ensembl ID : ENSAPOG00000005664
Gene Symbol: LOC110970708
2 Cross references
194 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSAPOG00000014556
Gene Symbol: UTS2R
4 Cross references
92 Possible Orthologues:

Utrophin

Ensembl ID : ENSAPOG00000008166
Gene Symbol: UTRN
2 Cross references
252 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSAPOG00000023547
Gene Symbol: VEGFA
3 Cross references
181 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSAPOG00000004962
Gene Symbol: VEGFAB
1 Cross references
198 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSAPOG00000012050
Gene Symbol: VDR
3 Cross references
392 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSAPOG00000012198
Gene Symbol: LOC110960330
3 Cross references
394 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like

Ensembl ID : ENSAPOG00000014583
Gene Symbol: LOC110946809
3 Cross references
190 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSAPOG00000020523
Gene Symbol: LOC110969573
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).